These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

687 related articles for article (PubMed ID: 28260880)

  • 1. Impact of comorbid conditions in COPD patients on health care resource utilization and costs in a predominantly Medicare population.
    Schwab P; Dhamane AD; Hopson SD; Moretz C; Annavarapu S; Burslem K; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():735-744. PubMed ID: 28260880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of roflumilast on exacerbations of COPD, health care utilization, and costs in a predominantly elderly Medicare Advantage population.
    Moll K; Sun SX; Ellis JJ; Howe A; Amin A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():565-76. PubMed ID: 25834417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. COPD exacerbation frequency and its association with health care resource utilization and costs.
    Dhamane AD; Moretz C; Zhou Y; Burslem K; Saverno K; Jain G; Renda A; Kaila S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():2609-18. PubMed ID: 26664109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population.
    Pasquale MK; Sun SX; Song F; Hartnett HJ; Stemkowski SA
    Int J Chron Obstruct Pulmon Dis; 2012; 7():757-64. PubMed ID: 23152680
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Burden of chronic obstructive pulmonary disease in Medicare beneficiaries residing in long-term care facilities.
    Simoni-Wastila L; Blanchette CM; Qian J; Yang HW; Zhao L; Zuckerman IH; Pak GH; Silver H; Dalal AA
    Am J Geriatr Pharmacother; 2009 Oct; 7(5):262-70. PubMed ID: 19948302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asthma and Chronic Obstructive Pulmonary Disease Overlap Syndrome: Doubled Costs Compared with Patients with Asthma Alone.
    Gerhardsson de Verdier M; Andersson M; Kern DM; Zhou S; Tunceli O
    Value Health; 2015 Sep; 18(6):759-66. PubMed ID: 26409602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors contributing to high-cost hospital care for patients with COPD.
    Mulpuru S; McKay J; Ronksley PE; Thavorn K; Kobewka DM; Forster AJ
    Int J Chron Obstruct Pulmon Dis; 2017; 12():989-995. PubMed ID: 28392683
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health Care Resource Utilization and Exacerbation Rates in Patients with COPD Stratified by Disease Severity in a Commercially Insured Population.
    Wallace AE; Kaila S; Bayer V; Shaikh A; Shinde MU; Willey VJ; Napier MB; Singer JR
    J Manag Care Spec Pharm; 2019 Feb; 25(2):205-217. PubMed ID: 30698096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of lung function on exacerbations, health care utilization, and costs among patients with COPD.
    Ke X; Marvel J; Yu TC; Wertz D; Geremakis C; Wang L; Stephenson JJ; Mannino DM
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1689-703. PubMed ID: 27555759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative study on medical utilization and costs of chronic obstructive pulmonary disease with good lung function.
    Lim JU; Kim K; Kim SH; Lee MG; Lee SY; Yoo KH; Lee SH; Jung KS; Rhee CK; Hwang YI
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2711-2721. PubMed ID: 28979113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Economic Burden of Comorbid Obstructive Sleep Apnea Among Patients with Chronic Obstructive Pulmonary Disease.
    Hong YD; Onukwugha E; Slejko JF
    J Manag Care Spec Pharm; 2020 Oct; 26(10):1353-1362. PubMed ID: 32996389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort.
    Wacker ME; Kitzing K; Jörres RA; Leidl R; Schulz H; Karrasch S; Karch A; Koch A; Vogelmeier CF; Holle R
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3437-3448. PubMed ID: 29270005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The economic burden of chronic obstructive pulmonary disease (COPD) in a U.S. Medicare population.
    Menzin J; Boulanger L; Marton J; Guadagno L; Dastani H; Dirani R; Phillips A; Shah H
    Respir Med; 2008 Sep; 102(9):1248-56. PubMed ID: 18620852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden in direct costs of concomitant chronic obstructive pulmonary disease and asthma in a Medicare Advantage population.
    Blanchette CM; Gutierrez B; Ory C; Chang E; Akazawa M
    J Manag Care Pharm; 2008 Mar; 14(2):176-85. PubMed ID: 18331119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of COPD, asthma, and ten comorbid conditions to health care utilization and patient-centered outcomes among US adults with obstructive airway disease.
    Murphy TE; McAvay GJ; Allore HG; Stamm JA; Simonelli PF
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2515-2522. PubMed ID: 28883718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of chronic obstructive pulmonary disease maintenance medication adherence with all-cause hospitalization and spending in a Medicare population.
    Simoni-Wastila L; Wei YJ; Qian J; Zuckerman IH; Stuart B; Shaffer T; Dalal AA; Bryant-Comstock L
    Am J Geriatr Pharmacother; 2012 Jun; 10(3):201-10. PubMed ID: 22521808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of hospitalizations/emergency department visits and treatment costs associated with initial maintenance therapy using fluticasone propionate 500 microg/salmeterol 50 microg compared with ipratropium for chronic obstructive pulmonary disease in older adults.
    Blanchette CM; Akazawa M; Dalal A; Simoni-Wastila L
    Am J Geriatr Pharmacother; 2008 Aug; 6(3):138-46. PubMed ID: 18775388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis.
    Ajmera M; Raval AD; Shen C; Sambamoorthi U
    Int J Chron Obstruct Pulmon Dis; 2014; 9():339-48. PubMed ID: 24748785
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin use and health care utilization in patients with coexisting chronic obstructive pulmonary disease and diabetes mellitus.
    Bishwakarma R; Zhang W; Lin YL; Kuo YF; Cardenas VJ; Sharma G
    Int J Chron Obstruct Pulmon Dis; 2018; 13():793-800. PubMed ID: 29551895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and economic burden of patients diagnosed with COPD with comorbid cardiovascular disease.
    Dalal AA; Shah M; Lunacsek O; Hanania NA
    Respir Med; 2011 Oct; 105(10):1516-22. PubMed ID: 21684731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.